LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024 authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470

Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024 authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470

Implementing Regulation (EU) 2024/1052 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   Calcidiol monohydrate is authorised to be placed on the market within the Union. Calcidiol monohydrate shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470. 2.   The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

Only the company DSM Nutritional Products Ltd.  ( 27 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of 5 years from 1 May 2024, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of DSM Nutritional Products Ltd.

Article 3

Open ↗

The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of 5 years from the date of entry into force of this Regulation without the agreement of DSM Nutritional Products Ltd.

Article 4

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) in Table 1 ( Authorised novel foods ), the following entry is inserted: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection ‘ Calcidiol monohydrate Specified food category Maximum levels 1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘‘calcidiol (calcifediol) monohydrate (vitamin D)’’. 2. The labelling of food supplements containing the novel food shall bear a statement that they should not be consumed by infants and children under 3 years of age/children under 11 years of age, depending on the age group the product is intended for.   Authorised on 1 May 2024. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. During the period of data protection, the novel food calcidiol monohydrate is authorised for placing on the market within the Union only by DSM Nutritional Products Ltd., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DSM Nutritional Products Ltd. End date of the date protection: 1 May 2029.’ Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children 10 μg/day for children from 11 years of age and adults 5 μg/day for children from 3 to 10 years of age (2) in Table 2 ( Specifications ), the following entry is inserted: Authorised Novel Food Specification ‘ Calcidiol monohydrate Description/Definition: The novel food is calcidiol monohydrate (25-hydroxycholecalciferol monohydrate). The novel food contains the monohydrate form of the major circulating metabolite of vitamin D 3 in the body and is a source of 1,25-dihydroxyvitamin D, the biologically active form of vitamin D. Conversion factor: 1 μg calcidiol = 2,5 μg vitamin D 3 for doses up to 10 μg/day. The production process of the novel food starts with a yeast fermentation which results in a mixture of sterols, with trienol being the major sterol obtained. After the fermentation, purification and several chemical steps follow. The chemical steps include saponification and extraction, where the trienol is isolated from the biomass. This is followed by a hydroxylation step to separate the trienol from the other sterols. Trienol is then epoxidised and subsequently reduced to give 25-hydroxydehydrocholesterol. A photoreaction follows, to obtain a mixture of 25-hydroxy-previtamin D 3 , 25-hydroxy-tachysterol and 25-hydroxy-lumisterol. Thereafter, the 25-hydroxy-previtamin D 3 is thermally isomerised to ‘‘Calcidiol’’ and recrystallized to obtain the novel food of the required purity. The novel food is intended to be placed on the market as a diluted form ‘‘0,25 % w/w’’, containing 0,250-0,275 % w/w of calcidiol (anhydrous). The novel food needs to be placed on the market in a preparation guaranteeing its stability. Chemical name according to IUPAC: (1S,3Z)-3-[( 2E )-2-[(1R,3αS,7αR)-1-[( 2R )-6-hydroxy-6-methylheptan-2-yl]-7α-methyl-2,3,3α,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; hydrate CAS Number: 63283-36-3 (Calcifediol monohydrate) Empirical formula: C 27 H 44 O 2 .H 2 O Molecular weight: 418,7 g/mol Characteristics/composition: 25(OH)D 3 .H 2 O: 97,0-100 % Total related substances: ≤ 1,5 %, of which: Δ 22 -25(OH)D 3 : ≤ 0,5 %; Lumisterol  ( 1 ) : ≤ 0,5 %; pre-25(OH)D 3  ( 2 ) : ≤ 0,5 %; Tachysterol  ( 3 ) : ≤ 0,5 %; trans-Vitamin D 3  ( 4 ) : ≤ 0,5 % Other impurities: ≤ 0,10 % Water content: 3,8-5,0 % Acetone: ≤ 1 000 mg/kg Isopropanol: ≤ 10 mg/kg Heavy metals: Arsenic: ≤ 1 mg/kg ( 1 )   9b,10a-Cholesta-5,7-diene-3b,25-diol (25(OH)). ( 2 )   Cholesta-5,7-diene-3b,25-diol. ( 3 )   (6E)-9,10-Secocholesta-5(10),6,8-triene-3b,25-diol (iso-25(OH)). ( 4 )   (5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol.’

Other acts of the same type
Commission Implementing Regulation (EU) 2022/2266 of 14 November 2022 entering a name in the register of protected designations of origin and protected geographical indications (‘Samoborska češnjovka/Samoborska češnofka’ (PGI))Commission Implementing Regulation (EU) 2022/2267 of 14 November 2022 entering a name in the register of protected designations of origin and protected geographical indications (‘Meso istarskog goveda – boškarina/Meso istrskega goveda – boškarina’ (PDO))Commission Implementing Regulation (EU) 2022/2203 of 11 November 2022 amending Regulation (EU) No 965/2012 as regards the applicability of the requirements for locating an aircraft in distressCommission Implementing Regulation (EU) 2022/2252 of 11 November 2022 granting a Union authorisation for the biocidal product family ‘Brenntag GmbH Propan-2-ol Product Family’ (Text with EEA relevance)Council Implementing Regulation (EU) 2022/2194 of 10 November 2022 implementing Regulation (EU) 2017/2063 concerning restrictive measures in view of the situation in VenezuelaCommission Regulation (EU) 2022/2195 of 10 November 2022 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of Butylated Hydroxytoluene, Acid Yellow 3, Homosalate and HAA299 in cosmetic products and correcting that Regulation as regards the use of Resorcinol in cosmetic products (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/2189 of 9 November 2022 amending Implementing Regulation (EU) 2021/1784 imposing a definitive anti-dumping duty on imports of aluminium flat-rolled products originating in the People’s Republic of ChinaRegulation (EU) 2022/2192 of the European Parliament and of the Council of 9 November 2022 laying down specific provisions for the 2014-2020 cooperation programmes supported by the European Neighbourhood Instrument and under the European territorial cooperation goal, following programme implementation disruptionCommission Delegated Regulation (EU) 2023/119 of 9 November 2022 amending Delegated Regulation (EU) 2020/692 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for entry into the Union, and the movement and handling after entry of consignments of certain animals, germinal products and products of animal origin (Text with EEA relevance)Council Implementing Regulation (EU) 2022/2177 of 8 November 2022 implementing Regulation (EU) No 401/2013 concerning restrictive measures in view of the situation in Myanmar/BurmaCouncil Implementing Regulation (EU) 2022/2179 of 8 November 2022 implementing Regulation (EU) 2017/1770 concerning restrictive measures in view of the situation in MaliCouncil Implementing Regulation (EU) 2022/2180 of 8 November 2022 implementing Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People’s Republic of Korea

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next